Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sedigheh Moradkhani"'
Autor:
Behrouz Alirezapour, Javad Mohammadnejad, Amir Reza Jalilian, Malihe Paknejad, Sedigheh Moradkhani, Saeed Rajabifar, Ehsan Maadi, Mohammad Javad Rasaee
Publikováno v:
Nuclear Medicine and Biology. 43:73-80
Objective Breast cancer radioimmunoscintigraphy targeting MUC1 expression is a growing field of work in nuclear medicine research. PR81 is a monoclonal antibody that binds with high affinity to MUC1, which is over expressed on breast tumors. In this
Autor:
Omid Sabzevari, Sedigheh Moradkhani, Yousef Fazaeli, Ali Khalaj, Amir Reza Jalilian, Fateme Bolourinovin, Nazila Gholipour
Publikováno v:
Radiochimica Acta. 102:1035-1045
In this study, zinc-62 was prepared at radiopharmaceutical grade (for 62Zn/62Cu generator production) using natCu(p, xn) reaction with the production yield of 5.9 mCi/μAh at 30 MeV proton energy (radiochemical separation yield >95%, radionuclidic pu
Autor:
Sedigheh Moradkhani, Amir Reza Jalilian, Ali Rahiminejad-Kisomi, Yousef Fazaeli, Saeed Rajabifar, Mostafa M. Amini, Fatemeh Bolourinovin
Publikováno v:
Journal of Radioanalytical and Nuclear Chemistry. 288:17-24
[67Ga]labeled tetraphenyl porphyrin ([67Ga]-TPP) was prepared using freshly prepared [67Ga]GaCl3 and tetraphenyl porphyrin (TPPH2) for 30–60 min at 25 °C (radiochemical purity: >97 ± 1% ITLC, >98 ± 0.5% HPLC, specific activity: 13–14 GBq/mmol)
Publikováno v:
Journal of Radioanalytical and Nuclear Chemistry. 285:555-561
In this work, recently prepared 67Ga-labeled glucagon (67Ga-DTPA-GCG) for imaging studies (radiochemical purity >94%; HPLC, S.A. 296–370 GBq/mM) was used in biological studies. The wild-type rat biodistribution results, 2 h post injection, demonstr
Autor:
Behrouz, Alirezapour, Mohammad Javad, Rasaee, Amir Reza, Jalilian, Saeed, Rajabifar, Javad, Mohammadnejad, Malihe, Paknejad, Ehsan, Maadi, Sedigheh, Moradkhani
Publikováno v:
Nuclear medicine and biology. 43(1)
Breast cancer radioimmunoscintigraphy targeting MUC1 expression is a growing field of work in nuclear medicine research. PR81 is a monoclonal antibody that binds with high affinity to MUC1, which is over expressed on breast tumors. In this study, we
Autor:
Yousef Fazaeli, Sedigheh Moradkhani, Abbas Majdabadi, Azar Bagheri, Fatemeh Rezaee, Tahereh Firouzyar, Amir Reza Jalilian
Publikováno v:
Journal of Radioanalytical and Nuclear Chemistry.
Developing radiolabeled tetrahydropyrrole complexes for ultimate dual-purpose imaging as well as dual-therapeutic modalities was of our interests. [67Ga] labeled radachlorin was prepared followed by stability tests, partition coefficient determinatio
Autor:
Khosro Ardaneh, Sedigheh Moradkhani, Yousef Fazaeli, Ali Rahiminejad, Mostafa M. Amini, Fatemeh Bolourinovin, Abbas Majdabadi, Amir Reza Jalilian
Publikováno v:
Nuclear medicine and molecular imaging. 46(1)
Due to the interesting pharmacologic properties of porphyrins, the idea of developing a possible tumor imaging agent using PET by incorporating (68)Ga into a suitable porphyrin ligand was investigated.(68)Ga-labeled 5,10,15,20-tetrakis(pentafluoro-13
Autor:
A. R. Jalilian, M. Kamali-dehghan, Mehdi Akhlaghi, Sedigheh Moradkhani, Kamaledin Shafaii, Azamolsadat Emami
Publikováno v:
Radiochimica Acta. 98
[ 61 Cu]-9,10-Phenanthrenequinone thiosemicarbazone ( 61 Cu-PQTS), a radiolabeled anticancer compound was prepared for malignant tissue imaging studies. Copper-61 was produced via the nat Zn(p, x) 61 Cu nuclear reaction in a 30 MeV cyclotron (150 μA
Autor:
Sedigheh Moradkhani, M. Kamali-dehghan, Amir Reza Jalilian, Saeed Shanehsazzadeh, Mehdi Akhlaghi
Publikováno v:
Radiochimica Acta. 98
Buserelin was successively labeled with [ 111 In]-Indium chloride after residuation with DTPA-dianhydride. Radio-chromatography showed an overall radiochemical purity of >90% (RTLC) and > 95% (HPLC) at optimized conditions after labeling (specific ac
Autor:
Behrouz Alirezapour, Mehraban Pouladi, Sedigheh Moradkhani, Gholamreza Aslani, Amir Reza Jalilian, M. Mirzaii, Saeed Rajabifar
Publikováno v:
Journal of Cancer Research and Therapeutics, Vol 10, Iss 1, Pp 112-120 (2014)
Context: Herceptin and its fragments have been radiolabeled and used in the imaging of human epidermal growth factor receptor 2 (HER2)/neu-positive tumors and development of diagnostic kits is of great importance in radiopharmacy. Aims: In this study